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Abstract
Chronic kidney disease stage 5 is a global health challenge in the context of population ageing 
across the world. The range of treatment options available to patients at all ages has increased 
and includes transplantation and dialysis. However, these options are often seen as inappropriate 
for older frailer patients who are now offered the option of conservative kidney management, 
which is presented as a non-invasive alternative to dialysis, involving symptom management 
and addressing psychosocial needs. In this study, we conducted qualitative interviews with 26 
close persons caring for someone with chronic kidney disease stage 5 in the United Kingdom 
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to investigate how conservative kidney management interacted with implicit ideas of ageing, in 
both the experience of conservative kidney management and the understanding of the prognosis 
and future care of the kidney disease. Our findings highlighted participant confusion about the 
nature of conservative kidney management, which stems from an initial lack of clarity about 
how conservative kidney management differed from conventional treatments for chronic kidney 
disease stage 5. In particular, some respondents were not aware of the implicit palliative nature 
of the intervention or indeed the inevitable end-of-life issues. Although these findings can be 
situated within the context of communication failure, we would further argue that they also bring 
to the surface tensions in the discourses surrounding ageing and old age, drawing on the use of a 
‘natural’ and a ‘normal’ paradigm of ageing. In the context of chronic kidney disease stage 5, more 
patients are being dialysed at older ages, but conservative kidney management is being advanced 
as a better option than dialysis in terms of quality of life and experience. However, in doing so, 
conservative kidney management implicitly draws on a notion of older age that echoes natural 
ageing rather than advocate a more interventionist approach. The role of discourses of ageing 
in the provision of treatments for conservative kidney management has not previously been 
acknowledged, and this article addresses this gap.
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Introduction
The nature of ageing and of old age has become an important dimension for understand-
ing health and illness in contemporary societies (Jones and Higgs, 2010). Once confined 
to the edges of health care and catered for by specialties such as geriatric medicine, the 
challenges and problems of individual longevity have forced mainstream biomedicine to 
have more contact with older patients and their problems. This has meant that services 
and procedures have had to adapt to this situation, but in doing so, implicit understand-
ings of what was ‘natural’ about ageing have become challenged by what has become 
‘normal’ about it (Pickard, 2011). Nowhere is this more clear than in the treatment of 
conditions such as chronic kidney disease (CKD), where there are now many older 
patients and questions about what kind of services are appropriate for them have become 
more salient. In this article, we argue that it is important to understand how the different 
discourses of natural and normal ageing influence the experiences and expectations of 
the ‘close persons’ providing care for a person with CKD with both physical and emo-
tional support. We assert that such discourses not only situate their satisfaction with 
services provided for older people with CKD but also provide an additional perspective 
on these engagements, one not always evident when looking at patient and providers 
alone.
The discourses of ageing have been described as ‘contested terrains’ by Jones and 
Higgs (2010) who have argued that longstanding ideas of ageing and old age as a ‘natu-
ral’ process leading to death have been radically destabilised by what is now accounted 
for as ‘normal’ ageing. Not only is there greater longevity, but for many individuals, 
there is also better health at older ages (Costa, 2005). Citing the biogerontologist Tom 
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Kirkwood, Jones and Higgs (2010) point out that not only has there been an extension of 
disability-free life but that many diseases and conditions that once had a poor prognosis 
for older people can now be the site of successful interventions (Kirkwood, 1999). 
Alongside this changing notion of what is normal in later life has come the imperative to 
continually push the boundaries of what is possible or expected from people at different 
ages. This can be in terms of lifestyle, exercise, or treatment. Consequently for Jones and 
Higgs (2010), these different discourses are indeed ‘contested’ with some writers such as 
Vincent (2009), arguing for a need to return to a normatively accepted idea of natural 
ageing, while others see this as both an impossible and retrograde step (Mykytyn, 2009). 
Nicholson et al. (2012) argue that the poor health of some very old people places them in 
a ‘liminal’ position, ‘betwixt and between’ active living and clinically recognised dying. 
It is within this context that our research into the experiences of close persons caring for 
people with CKD on conservative management is located.
CKD is establishing itself as a global health challenge in the light of global population 
ageing. The range of options now available to patients with CKD of all ages has greatly 
increased. From a biomedical perspective, those affected by CKD will experience a grad-
ual deterioration in kidney function and may develop chronic kidney disease stage 5 
(CKD5), clinically defined as a glomerular filtration rate (GFR) <15 mL/min/1.73 m2 
(Levey et al., 2007; The National End of Life Care Programme, 2008), where they will 
need renal replacement therapy (RRT) options such as dialysis and kidney transplanta-
tion if they are not to die. However, even at this stage, death is not inevitable as decline 
in renal function may be very slow and survival can be for many months to years. Within 
the field of nephrology (renal care), advances in biotechnology have seen improvements 
in the way that dialysis is delivered, and these have changed assumptions about age and 
status of older patients. When the first kidney dialysis outpatient unit was opened in 1963 
in Seattle, USA, dialysis was rationed to people of working age (Blagg, 2007). Current 
technological advances now make it possible for dialysis to be made available to those 
who would have previously been seen as too old for the treatment. However, as dialysis 
is the only RRT option available to the majority of older patients with CKD5, given the 
extent of their comorbidities, it would now seem as if this option has become 
normalised.
At the same time, however, dialysis is a physically demanding treatment that might 
take a toll on some physically frail older people and may not necessarily lead to any 
improvement in survival or health-related quality of life (Carson et al., 2009; Murtagh 
et al., 2007; Smith et al., 2003). For this group of patients, the recent development of 
conservative kidney management (CKM) offers an alternative to dialysis. With its 
emphasis on both the management of symptoms associated with deteriorating kidney 
function and a concern for the psychosocial issues that emerge as health deteriorates 
(Murtagh and Sheerin, 2010), CKM is now established in several industrialised countries 
(De Biase et al., 2008; Morton et al., 2012; Smith et al., 2003). In the United Kingdom 
and Australia, it is estimated that 14% of those with CKD5 receive CKM (Carson et al., 
2009; Morton et al., 2010; Murtagh, 2009). One argument raised in this article is that 
while CKM may be offered as an alternative to dialysis, it seems to overlap with the 
discourse of natural ageing insofar as treatment is replaced by management rather than 
being organised around active intervention. In choosing not to undertake an active 
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treatment of dialysis, there is an implicit idea that the patients with CKD5 are accepting 
that they are on a relatively unpredictable trajectory towards death that is in many ways 
a part of what previously was seen as natural ageing. That this is an important distinction 
operating at both clinical and social levels is marked by the fact that in the study we are 
about to report the differences between management, and treatments are not always clear 
to those closest to the patient, while the choices are very distinct to the clinical teams 
who are implementing them.
In this article, we report on a multi-centre qualitative study with close persons of those 
with CKD5 receiving CKM in five UK renal tertiary referral centres with well-estab-
lished CKM provision. By close persons we mean the individual, either a family member 
or friend, identified by the patient as the major provider of their physical and emotional 
care needs, and who is neither a volunteer nor in the employment of statutory services 
(Low et al., 2008). We report close persons’ past and current experience of caring for 
people opting for CKM, their thoughts about end-of-life care and whether current sup-
port systems adequately respond to close persons’ physical, emotional, and social needs. 
Unlike previous studies looking at this area (Ashby et al., 2005; Low et al., 2008; Morton 
et al., 2010), we will seek to show how the discourses around ageing and old age play an 
implicit role in shaping the experiences of this group of close persons caring for someone 
with CKD5 on conservative management.
Methodology
In recruiting our sample of close persons, we consecutively approached people with 
CKD5 who were being conservatively managed and attending clinic in five tertiary renal 
centres in Southeast England between December 2009 and July 2010, to identify the key 
person providing the majority of their physical and emotional support. We then purpo-
sively sampled our participants for gender, age, ethnic background, their relationship to 
the person with CKD5, the clinical condition of the person, and the renal unit where they 
were being conservatively managed. Provided the person had given his or her initial 
consent for us to contact his or her close person, our research team approached these 
close persons about participation into the study. Close persons were excluded if they 
were caring for someone actively being considered for transplantation, were under 18 
years, or acting through a voluntary agency or statutory services.
We identified 38 eligible close persons, of whom 26 gave consent to be interviewed 
(Table 1). Our sample were mainly women (15/26), White British (17/26) and a mean 
age of 63 years (SD = 14). In reflecting the age of our sample, most participants were 
either employed or seeking employment (18/26), but only 6 were in full-time employ-
ment. Most participants were either adult children or children-in-law (14/26), caring for 
people with high comorbidity requiring considerable care and with a median GFR of 10 
mL/min who had been on CKM for a median of 14 months. Of the 12 who did not par-
ticipate, four were too busy, two were too distressed, and three gave no reasons. A further 
three were not approached as the person they were caring for did not give consent.
The research associate (J.M.) interviewed consenting participants in a place of their 
choice, usually at home, and five of the interviews took place in the presence of the per-
son with CKD5. In collecting the data, we used a narrative approach to explore: in-depth 
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participants’ experience of caring for someone on CKM from the time of CKD diagnosis, 
the person’s decision about CKM, their relationship with health and social services, and 
how they viewed the future. We audiotaped interviews, which lasted between 20 and 90 
minutes, with the participants’ consent.
All interviews were transcribed verbatim and imported into NVivo (version 8.0), a 
software package used to aid storage, coding, and searching of data. Transcripts were 
initially analysed thematically by J.M. following a chronological pattern from the diag-
nosis, to the everyday experience of caring, through to their future thoughts and feelings 
about the experience of caring for someone on CKM. We then explored the themes using 
a framework of ageing and disability, to see how these two concepts impacted on the 
experiences of close persons in caring for an elderly person with CKD5. To ensure valid-
ity and reliability, theme generation was also carried out independently by J.L. and J.M., 
who subsequently discussed their analysis with G.S. The main findings were brought to 
multi-disciplinary steering group meetings (including clinicians from nephrology and 
Table 1. Sample characteristics of the close persons and the key demographics of person they 
provide care to.
Pseudonyms Relationship 
with person
Age 
(years)
Gender Ethnicity Person 
gender
Person age 
(years)
Time on CKM 
(months)
Person 
eGFR
Mary Daughter 61 Female White British Male 91 25 14
Ken Husband 87 Male White British Female 87 5 10
Chris Husband 71 Male White British Female 72 1 15
David Husband 78 Male White British Female 81 17 8
Victor Husband 81 Male White British Female 87 21 6
Gina Daughter 56 Female British Italian Male 87 5 7
Phillip Son 59 Male White British Male 87 5 8
Jan Daughter 53 Female White British Female 85 27 12
Shona Niece 42 Female Black Caribbean Male 91 12 12
Pam Daughter 54 Female White British Female 92 31 11
George Son 60 Male White British Female 96 5 8
Susan Sister 72 Female White British Male 80 16 10
Rosie Daughter 35 Female Black Caribbean Female 63 10 6
Nelson Friend 51 Male Black African Male 61 58 14
Nick Son 64 Male White British Male 89 61 10
Donna Daughter 58 Female Black Caribbean Female 88 2 10
Winston Husband 87 Male Black British Female 78 4 13
Doris Wife 59 Female White British Male 61 20 9
Jeff Son-in-law 64 Male White British Male 91 7 10
Alice Daughter 70 Female Black Caribbean Female 96 16 14
Denise Daughter-
in-law
58 Female White British Female 80 11 10
Munisa Daughter-
in-law
38 Female South Asian Female 78 10 13
James Son 64 Male White British Female 95 84 10
Nita Wife 69 Female South Asian Male 90 23 11
Ivy Wife 91 Female White British Male 93 30 12
Sandra Friend 53 Female White British Female 78 14 10
 at University College London on December 11, 2014hea.sagepub.comDownloaded from 
618 Health 18(6) 
palliative care) to resolve discrepancies and reach a consensus on interpretation of texts. 
In presenting the results, we refer to close persons as ‘participants’ and the person with 
CKD5 whom the close person was providing care to as ‘the person.’
In conducting this study, we first obtained ethical approval from the Brompton, 
Harefield & NHLI Research Ethics Committee (09/H0708/32).
Results
We draw on our data to explore how participants caring for a person on conservative 
management interacted with the themes of treatment, ageing, and death. For the purpose 
of analysis, we have organised the data into four specific domains as they related to the 
accounts of the respondents. These were (a) awareness of the onset of CKD, (b) CKM, 
(c) discourses of ageing in relation to health and social care, and (d) negotiating the dis-
course of ageing and death.
Awareness of the onset of CKD
Most participants became informal carers of a person with CKD5 when either their 
relative or friend began to lose functional independence as a result of age-related 
frailty. Many participants had been engaged in various aspects of caring such as sup-
porting the person with their activities of daily living or managing their complex medi-
cation before the diagnosis of CKD. Significantly, people with CKD had multiple 
comorbidities that accompanied the renal condition, and most participants were already 
receiving some support from a range of health- and social care professionals as part of 
their caring role.
The transition to being identified as reaching CKD5 has little specific symptomatol-
ogy, but rather marks a watershed in relation to the treatment of the disease. Consequently, 
most participants did not perceive a dramatic change in the condition of a person with 
CKD5, but became aware of the fact that CKD5 was a disease of slow deterioration, 
which many saw as part of ageing:
She is, even with this 8 to 10% renal function, is just kind of jogging along. She’s very small, 
very frail, doesn’t eat a lot and somehow her body has adjusted with the aid of the medication, 
it adapted somehow. She doesn’t feel ill with it, she, her problem is simply confidence in 
walking. (James, son, 64 years)
Insofar as many of the participants felt that the condition was age related, there was 
also a feeling that it was their moral responsibility to provide good quality care to enable 
the person with CKD to remain in the person’s own home:
We have to keep everything clean just in case the health people come and say that she is not fit 
to live here or something, that is a worry for me. But I mean I don’t see it as that big of a 
problem because I see it as my job, it is my duty. She is my mother. I am African and there 
people stay in the house, you never put your parents in a home so I don’t want my Mother to go 
into a home. (Alice, daughter, 70 years)
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Younger and fitter participants related to the person with CKD were able to be more 
engaged in providing the person with a more comprehensive level of emotional and 
physical support. In addition, they often acted as an intermediary between the person 
with CKD and professional and statutory services:
I just felt that [my father-in-law] wasn’t totally listening to what [the health professional] was 
saying. Anyway, like I say, they explained it [the renal condition] all to me. (Jeff, son-in-law, 64 
years)
However, older participants in poor physical health had to rely on wider family net-
works and local neighbours to provide additional input in supporting the person with 
their activities of daily living, shopping, and in accessing health care.
For all participants, pressures related to how they performed their tasks and what 
resources could help were recurring themes. They often articulated a fear that the situa-
tion would get worse, requiring the person leave their home and to move to more shel-
tered accommodation. Susan, when discussing the challenges of dealing with the 
consequences of the persons’ deteriorating health, stated,
The first sort of thing we would go through is for him to have more help at home and see how he 
copes with that and should he have to go somewhere, that can’t be avoided. Obviously, he would 
prefer to be at home and it is something that you can’t know what is going happen, so you have 
got to wait until it does happen to see how you are going to cope. (Susan, sister, 72 years)
All of our participants saw the health-care problems associated with CKD as being 
indistinguishable from the ageing process of deterioration and decline. Consequently, 
their accounts are very similar to those of other carers of older people (Montgomery 
et al., 2007). One notable aspect of their accounts is that there is nothing specific about 
CKD in their experiences of caring either before or after the onset of CKD5. The only 
point of concern is what happens when the person with the condition needs more care 
than can be provided at home. There is an assumption that there will be an institutional 
solution. As we go on to show, CKM does not address this issue or provide a clinical 
pathway. Instead, the emphasis is on managing symptoms in the context of ordinary care, 
which assumes that death follows a natural ageing trajectory.
Conservative kidney management
Given that most of the caring undertaken by our participants was very similar to that 
provided by other carers of older people, we need to address how CKM related to the 
care of people with CKD5. The first point that needs to be brought out is that CKM is 
offered as an alternative to dialysis, so that all those on it have elected to take this route. 
This decision is not without its problems, as it is a decision to let the disease progress in 
a managed way. Consequently, participants may find such a decision difficult. Not all 
participants were involved in the person’s decision not to choose dialysis. Those partici-
pants who felt that dialysis was not a good option did so because of the age of the person 
they were looking after as well as the perceived lack of benefit that dialysis would 
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accomplish, and the disruption to their day-to-day life in contrast to the stability of the 
renal condition. Often, the participant would rationalise the decision from the perspec-
tive of the person, illustrated by Jan, a daughter, who had first discussed the issue of 
dialysis with a health professional 5 years earlier:
She (Jan’s mother) didn’t feel that it would be much quality of life (being on dialysis). I think she 
would just take the view that that would be the end of her life. Not that she was defeatist and gave 
up, but she couldn’t face the thought of being on the dialysis machine. (Jan, daughter, 53 years)
Participants’ acceptance of the person’s decision was influenced by the perception 
that CKM was both non-invasive and a continuation of the type of care that the person 
had first received following their referral to the renal teams via the low-clearance clinics. 
However, many participants had difficulty in defining what CKM was and had to refer 
back to attending outpatient renal clinics with the person to understand what CKM was 
trying to achieve. Moreover, CKM was seen by participants as both a more convenient 
and an appropriate way of managing CKD5, particularly as they did not see it affecting 
the person’s overall health. Acceptance of the person’s choice not to dialyse was based 
on the seeming inappropriateness of these biotechnologies and potential difficulties of 
the person preparing himself or herself for dialysis, as opposed to a specific understand-
ing of what CKM was as one participant described:
Then they talked about dialysis and the options which would basically have been [names of two 
local renal units], both of which are quite inaccessible to [the person], unless she’s got me with 
her. Her whole feeling was, if I’ve only got this much time left, I’m not going to spend three 
days of every week hooked up to a machine. Home dialysis was out of the question, because 
her flat is absolutely tiny, so she chose the other route. (Sandra, friend, 53 years)
Some participants sought to gain greater understanding of CKM. Phillip had exten-
sive discussions with his father about the decision whether to dialyse using Internet 
research:
Research has shown that people his age who have had dialysis with kidney function of around 
15% live on average 3 years and maybe these people who do this conservative management 
may be 2 to 3 years, so there is not a huge improvement. I think that results to (the nephrologist) 
statement it doesn’t improve the quantity or quality. Dad is quite understanding now, that this 
sort of conservative management is the best. (Phillip, son, 59 years)
A few participants disagreed with the decision of the person they were caring for not 
to dialyse. This resulted sometimes in a tension in accepting the person’s choice of treat-
ment. For these participants, dialysis was viewed as a life saver that could prolong the 
person’s life, and they felt anxious that choosing CKM would mean losing the person at 
an early stage of the disease progression. However, they often reluctantly accepted the 
choice of CKM because the option of dialysis was still available:
Well, that’s her decision I mean I have been trying to persuade her to have dialysis but it’s not 
my call I mean it’s up to her. It’s her life and her body, but I don’t particularly want to lose her, 
you know. I want her to stay with me but I mean obviously at the end of this, she is going to die 
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if she stays as she is but they told her that the option to have dialysis at the end of this if she gets 
worse is still open. (Chris, husband, 71 years)
The concept of natural ageing is central to understanding participants’ acceptance of 
the person’s decision to be conservatively managed. For most participants, their accept-
ance of the decision was based on their perceptions of dialysis as an inappropriate bio-
technology, disrupting the person’s lifestyle without offering any life-extending benefit. 
Therefore, the person’s rejection of dialysis meant that CKM was the only alternative 
available, which most participants accepted on the basis that CKM would cause less 
disruption to themselves and the person. Hence, it would initially appear that partici-
pants’ acceptance of CKM would support the notion of natural ageing, which partici-
pants acceptance of the person’s inevitable decline in health. However, the ability to 
reverse the decision for CKM also demonstrates the blurring of the boundaries between 
natural and normal ageing. For some participants, CKM is only accepted in the context 
of perceived stability in renal function and can be reversed if renal function deteriorates 
and the person wants to be dialysed.
Discourses of ageing in relation to health and social care
For many people, the onset of CKD was initially managed by their general practitioner, 
up to the point that the renal functioning deteriorates to a certain level (usually when the 
person reaches CKD stage 4). At that point, the person was then seen by renal health 
professionals in ‘low-clearance’ clinics, which facilitated new relationships between par-
ticipants and these professionals. The onset of CKD5 may initially have had a low impact 
on their experience of caring, but the person’s decision to be conservatively managed 
enabled a continuation of these relationships with renal health professionals who were 
engaging to various degrees with CKM, as a response to the complex medical regimens 
required to manage CKD5 conservatively.
In these relationships with renal health professionals, continuity of care was an impor-
tant theme for participants. For them, it was important that they saw the same set of 
professionals over time, or at least to know that medical information was being shared 
across the renal teams and with other medical specialities. However, this often chal-
lenged the person’s multiple comorbidity. Again, while the theme of having a good rela-
tionship with professionals is one that most participants expressed, they often did not 
understand what CKM involved and how it would affect the person who they cared for. 
There was a perception that the person was receiving health care from clinicians who 
understood the disease trajectory and could effectively manage it. However, participants 
acknowledged that as non-clinicians, they were not technically skilled in differentiating 
between good or bad care:
Of course I wouldn’t know competence from incompetence but you understand what I mean 
they are extremely competent in the way that they deliver everything; very considered, soft, 
detailed - they are very good. I couldn’t say otherwise. (Nick, son, 64 years)
For participants, involvement with the renal team increased if the person’s renal symp-
toms started to deteriorate. In these cases, as part of their responsibility of managing 
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patients conservatively, renal teams began to play a far greater role in advising both par-
ticipants and the person in how to manage these symptoms. In addition, they also began 
to make initial arrangements for palliative care:
When final failure really comes, the renal consultant said, it would be about a month that 
you would have of life. We don’t know when it’ll come; we hope it will be a long way away, 
but when it does that’s what you need to expect. So that was good actually to kind of broach 
these things. The renal nurse has broached… has organized the palliative care. (James, son, 
64 years)
This apparent satisfaction with how participants feel that CKM is ‘managing’ the 
person with renal disease is challenged by the onset of an emergency medical crisis for 
the person. In these situations that mainly happened outside of the hospital environment, 
participants spoke of their vulnerability in dealing with emergency medical situations 
(especially out of hours and weekends) if the person they were looking after was ill. 
These emergencies often challenged the notion that renal disease and medical care could 
be ‘managed’ with minimal medical intervention:
There has been many times when I have thought ‘what do I do now?’ Sometimes his haemoglobin 
levels drop ridiculously low and it happens overnight so quickly. I don’t know whether to call 
an ambulance or whether to take him through casualty. All these sorts of things are difficult 
decisions to make, as I’m not a professional. (Mary, daughter, 61 years)
The notion that the health of the person was generally stable but could deteriorate 
quickly meant that there was considerable uncertainty about what constituted an urgent 
problem. They also often felt they were not entitled to any health-care support, even with 
assurances from the renal team:
I know how much workload they have got and I don’t like to worry them with anything unless 
it is really serious for me. I could ring them up at any time and ask them a question but I just I 
would only do that if it was really urgent. (Mary daughter, 61 years)
Many of the difficulties faced by our participants were common to the circumstances 
faced by close persons caring for frail older people (Montgomery et al., 2007). For some 
participants, there was confusion about the management of the persons’ wider health 
needs which were in addition to CKD and which did not get included in CKM. 
Consequently, they often received conflicting medical information and un-coordinated 
care, as each medical speciality appeared to be treating their disease-specific symptoms 
without consulting each other:
He went to see the renal doctor who prescribed him some medication for blood pressure and 
then the cardiology doctor a week later stopped it and said he didn’t think it was good. But prior 
to him [the person] seeing the renal doctor when he was discharged from the hospital, cardiology 
actually put him on this medication. So they put him on, then they take him off then putting him 
on and at the moment, we are thinking who is going to give him what for his blood pressure. 
(Gina, daughter, 56 years)
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Problems with the role and remit of social services departments were often seen as 
problematic. While one participant appreciated the financial advice given by social ser-
vices, most struggled in getting social services to respond to the additional health needs 
of someone on CKM:
I was concerned when she came out [of hospital] that she wouldn’t be able to bath herself. So 
I phoned up the social services and they said, ‘well, we can’t tell you [about progress] until 
the people have seen her in hospital.’ And I said, ‘well, can you assure me that if she comes 
out somebody will be able to help me?’ They said, ‘oh, I can’t tell you.’ (George, son, 60 
years)
CKM was developed as an acknowledgement of the need to provide appropriate care 
to a group of mainly elderly people with declining health, which includes support for 
their close persons. Our findings demonstrate that for participants, issues of continuity of 
care were important in much the same way that they are for many older people with 
health-care needs. The process of CKM although identified as a clinical intervention by 
professionals often failed to be perceived as that by participants who viewed it as being 
connected with the health-care problems of ageing.
Negotiating the discourses of ageing and death
Nearly all participants accepted that the person’s kidneys would eventually stop func-
tioning and could be one of the potential causes of their death. However, for most 
participants, the perceived stabilisation of the persons’ CKD5 on CKM meant that 
many were happy to continue the process of being monitored without the need to 
explore more about the implications of the persons’ kidney disease. For other partici-
pants, there was a lack of understanding concerning the prognosis of someone on 
CKM, a limited knowledge of the treatments available for CKD5 and an unwillingness 
for them and the person they were caring for, to discuss the future as it often led to 
confusion and anxiety trying to predict when the persons’ kidney function would 
decline and death would result.
Participants managed this uncertainty by adopting a ‘mindful’ approach focused on 
living in the present, while viewing the future as based on current levels of renal func-
tioning. Indeed, a lack of medical evidence about potential future decline was used by 
several participants to embrace the future with feelings of hope rather than despair:
We are even planning going away next Christmas and the way I look at it, we are not worrying 
about it because we don’t know what is going to happen. (Ken, husband, 87 years)
Nelson did not accept the inevitability of kidney deterioration, but instead, using his 
own knowledge gleaned from family experience of renal disease (information not shared 
by those from the renal team), suggested a more positive prognosis. For this person eat-
ing a good diet could improve kidney function. As a result he saw his role as encouraging 
the person to eat a balanced diet more regularly and by doing so supporting the patient 
psychologically:
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His condition can improve. No situation is stable really nothing stays the same everything 
hopefully changes hopefully for the better. I think it is number one priority that he needs to eat 
a balanced diet. Not once in a while. Not once in a blue moon. Every day. (Nelson, friend, 51 
years)
Other participants felt that detailed discussions with the person they cared for about 
the prognosis of renal failure would highlight issues of impending death and would upset 
the person further:
I wouldn’t like, personally myself, I think it’d probably upset her. But she knows she’s got 
kidney problems that could affect her yeah. But I don’t know if it’s a good idea to tell her. 
(Munisa, daughter-in-law, 38 years)
However, acceptance by both participant and the person on CKM about the frailty of 
the latter’s health was often the key to getting both parties to discuss the future and the 
involvement of palliative care teams. Unfortunately, this acceptance was not sufficient to 
tackle issues on preference for future care if both the participant and the person had dif-
fering views on where they wanted the latter’s end-of-life care to be. For example, some 
participants were aware that the person they were caring for wanted to die at home, but 
were reluctant to support them with their wish. For these participants, past negative expe-
riences of supporting another person die at home, either on account of the stress and 
anxiety it had caused, or its association with negative memories left by the dying process 
on the home environment made them wish that the person on CKM died in hospital or in 
a hospice:
Well, I think he’d like to be at home ‘cause his wife died at home, but there were two of us there 
(supporting the wife to die at home), he was there, and obviously he was reasonably active then, 
and myself. But there’s nobody there (at the person’s home), I don’t really want to do that again. 
I was up there three, four nights a week, and plus the days, so, I mean, I didn’t have a life for 
three months. (Jeff, son-in-law, 64 years)
One participant had discussed the place of death with the person they were caring for. 
However, this discussion seemed to favour the needs and feelings of the participant over 
that of the person being cared for in that it was important for the person being cared for 
to die in a hospice. This is because she felt that if the person died at home, it would cause 
too much distress and anxiety not only for herself but also her family, and that her moth-
er’s death – the person on CKM – would be better managed in a hospice rather than at 
home with minimal medical intervention and expertise:
The hospice is our option [during the person’s demise] as they have the expertise and I think 
that it calms the anxiety and I am around people who know what they are doing. I also have a 
[young] son so my Mum dying here is not an option. He lives in the house and I want to keep 
as much trauma away from him as possible. I don’t want doctors rushing in and making him[the 
son] feel more anxious. (Rosie, daughter, 35 years)
For some participants, there was acceptance by both these participants and the per-
son they were caring for about the latter’s deteriorating health. In these cases, such 
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discussions with health-care teams had taken place about future palliative care arrange-
ments. Nevertheless, discussions about end-of-life issues most often focused on practi-
cal issues such as funeral arrangements, rather than emotional ones:
She’s determined I should arrange her funeral before [her death]. She keeps asking me, and 
when she says have you done it, I know what she’s talking about. I think she has more or less 
accepted that she’s had a long life. (Alice, daughter, 70 years)
Our findings showed that most participants acknowledged the deteriorating nature of 
the persons’ health condition, but also illustrate the different ways that they negotiated 
this. For many, the lack of evidence for medical decline enabled them to negotiate their 
future to one based on hope. Some have accepted the ‘inevitable decline’ by accepting 
input from specialist palliative care teams and by focusing on preparing for practical 
tasks such as funeral arrangements. However, challenges to future preferences for care 
and death arise where a difference exists between the participant and the person. Our 
findings demonstrate that participants saw the poor health of the person as somewhere 
between active living and clinically recognised dying, thus supporting the concept of the 
‘liminal’ position put forward by Nicholson et al. (2012).
Although one of the stated aims of CKM is the preparation of people with CKD5 for 
good end-of-life care, our findings suggest that discussions about preferences on future 
care need to be tailored depending on the readiness of participants to discuss these issues 
with health professionals and/or the person.
Discussion
Our study aimed to explore the impact of age and disability on the experience of close 
persons caring for a person with CKD5 on CKM. Our findings would appear to support 
the idea that CKM is organised around the discourses of ‘natural ageing’ where later life 
is seen to be defined by decline and eventual death – even though this is itself becoming 
confused and subject to partial medicalisation (Jones and Higgs, 2010). This theme is 
evident in the fact that the reality of CKM for many participants is similar to the caring 
of other frail older people (Montgomery et al., 2007). Tensions with this discourse of 
natural ageing can arise because of the nature of CKD.
The choice between adopting an intervention of dialysis or accepting a strategy of 
CKM is the first line of tension between what has become seen as ‘normal ageing’ with 
its emphasis on treatment and a more passive ‘natural ageing’. Crucially, the implied 
nature of old age and ageing appears to intervene as a variable in how these options are 
thought about as well as how they influence experiences. As we have written in the ear-
lier sections of the article, conditions such as CKD could have been seen in the past as 
one of the conditions associated with old age that inevitably led to death. In such circum-
stances, CKM would not seem to be so much a specific clinical option but rather the 
natural response to a biological finitude. The advances in renal medicine have changed 
this assumption, at least for those who are seen to be capable of benefiting from dialysis. 
This transformation from those with the condition being seen in terms of natural ageing 
to being seen as part of the creation of a new and changing normal ageing is highly 
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problematic for those dealing with its boundaries. As the evidence of participants in this 
study shows the condition of the person dealing with CKD does not seem to change dra-
matically if not treated with dialysis. At the same time, there is a clinical awareness of the 
fact that it is now a terminal prognosis rather than one with a possibility of survival. It is 
therefore not surprising that some participants in the study are unhappy with the deci-
sions made by the person they are providing care to. The comorbidities can be seen as 
part of their older lives and as things to be dealt with rather than indicators of a closing 
down of options. Equally, they can be seen as the reason not to add the stresses and 
inconveniences of dialysis to the lives of already frail individuals.
The theme of the boundary between the idea of natural ageing and the expectations of 
normal ageing reoccur throughout the comments of the participants. While the majority 
feel that they have good relations with the staff who are dealing with the CKD, it was 
apparent that as conditions associated with the trajectory of decline became apparent, 
there were difficulties with other health professionals who tended to treat the patient in 
relation to their various comorbid conditions that was seen to relate to their older age 
rather than their CKD. This is specifically so in the case of social care, where many par-
ticipants’ dissatisfaction arises from the lack of procedures within social care agencies to 
deal responsively and flexibly to health-care problems. It is at this point that, perhaps, the 
real underlying nature of CKM becomes apparent.
The issue of the two discourses of ageing also emerges most poignantly in relation to 
our theme of planning for the future, where perhaps the combination of the uncertainty 
of the nature of CKM and the difficulty of dealing with the emotional issues surrounding 
terminal illness and death combine to create a situation where to all intents and purposes 
the idea of normal ageing is maintained. In line with the concepts of natural ageing, 
CKM is seen as presenting both resources and potential opportunities for both partici-
pants and the person to negotiate end-of-life care planning with relevant health profes-
sionals. However, unless both the participants and the person accept the terminal nature 
of CKD5 and have a common view about the place of end-of-life care, tensions will 
exist. One of the main contradictions highlighted in these findings exists between the 
philosophy of CKM, as supporting participants with end-of-life issues and the realities 
illustrated by most participants, who do not see CKM as dealing with end-of-life issues, 
but as a way of living for the present without the inconvenience of dialysis. Potential 
issues may arise as the number of symptoms increase with worsening renal functioning.
Although our article illustrates the relative satisfaction that both family members and 
friends had of the care provided by renal services, it also illustrated that continuity of 
care was needed not just in the patient journey in the management of one of their comor-
bid conditions, but in the management of their whole disease spectrum. More generally, 
however, what our study throws light on is the impact of the changing nature of later life 
on how health and medicine are experienced and understood. The improvements in the 
health of older people mean that much more can be expected of older people in terms of 
how they pursue the ‘will to health’ (Higgs et al., 2009) in their own lives. However, as 
we have also shown in this article, this also puts into stark relief those for whom the 
options look much more limited. For this latter group, a return to the normative structures 
of natural ageing has become problematic as these structures have also been destabilised 
by the social changes that have been brought about by a healthier older population. As 
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Vincent (2009) points out, the loss of the normative structures that in the past helped 
place natural ageing in a cultural context has made it harder for people in contemporary 
society to negotiate illness and death as anything other than a series of health- and social 
care interventions. In the context of our study, it leads to the conclusion that the issues 
surrounding kidney disease in older patients need to be understood in the context of 
wider discourses of ageing and old age. By developing CKM programmes, health service 
planners have increasingly recognised the limitations of biomedicine in delivering 
acceptable health care for an increasing older and frail population. However, a major 
limitation of these services for both the person with CKD5 and their close person is that 
these services operate by focusing on a specific disease and operate on the context that 
ageing is not important, whereas this article shows that ageing is critically important.
Specific implications for clinical practice include two important issues, which 
impact on delivery of health care to a population with multiple comorbidities. First, the 
lack of awareness regarding the complexity of medical care delivered specifically for 
the renal condition was surprising. The close persons and by inference the person him-
self or herself did not view their CKD care as distinct from his or her other medical 
problems. Little comment was made about the benefit of having expert renal care 
although there was appreciation of the work of the renal teams. These findings illus-
trate the difficulties in providing seamless patient-centred care, while maintaining 
disease-specific treatment across multiple specialist services. The second challenging 
service issue identified relates to anxiety about what actions the close person take 
should the person get into difficulty outside of routine hours. Dedicated 24-hour hel-
plines may help, but have not been evaluated and are likely to be costly. In addition, 
optimal treatment of acute events generally necessitates prompt action and temporary 
omission of many of the treatments designed to maintain stability under ordinary cir-
cumstances. Success depends upon timely expert knowledge, experience, clinical skill, 
and regular short-interval review and revision of care plans. Clearly, these key compo-
nents are difficult to provide out of hours for every person with CKD5, yet they are 
important concerns for their close persons.
In conclusion, this article has sought to draw out the importance of ageing, both natu-
ral and now normal, for people with CKD5, and their close persons. It has shown that 
what might be very obvious for clinicians is not necessarily so clear for patients and oth-
ers. Drawing out the implications of CKM is a challenge for clinicians if it is to avoid 
some of the pitfalls identified by this study.
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